Oesophageal cancer, Stomach cancer
Results
Phase 3
This trial looked at chemotherapy with or without panitumumab (Vectibix) for cancer of the oesophagus, stomach or cancer that started where the oesophagus meets the stomach. This is called gastro oesophageal junction cancer. The trial was for people with cancer that had spread into surrounding tissue or to another part of the body (advanced) and who were unable to have surgery. This trial was supported by Cancer Research UK.
Recruitment start: 20 May 2008
Recruitment end: 19 October 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Cunningham
Amgen
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research Cancer Research Network (NCRN)
The Royal Marsden NHS Foundation Trust
This is Cancer Research UK trial number CRUKE/07/049.
Last reviewed: 11 June 2013
CRUK internal database number: 1711
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
